

Please try another search
BEIJING (Reuters) - China's Shanghai Fosun Pharmaceutical Group Co Ltd is willing to provide Taiwan with BioNTech COVID-19 vaccines, its chairman Wu Yifang told Xinhua news agency, amid a spike in domestic infections on the island.
Fosun signed a deal with BioNTech to exclusively develop and commercialise COVID-19 vaccine products developed using BioNTech's mRNA technology in mainland China, Hong Kong, Macau and Taiwan.
BioNTech's development and distribution partner for the rest of the world is U.S. firm Pfizer Inc. (NYSE:PFE)
Wu said certain groups in Taiwan he did not name had been in touch for an emergency purchase of vaccines and the company was willing to "provide vaccine services to Taiwan compatriots".
Since last year, Fosun has been promoting vaccines for Taiwan, Wu said, adding they hope shots can arrive on the island soon to help prevent a resurgent spread of the virus.
Fosun did not immediately reply to a Reuters request for comment.
Taiwan's government has said it is talking with BioNTech rather than Fosun, and that the two sides were on the verge of announcing a deal in December when BioNTech pulled the plug.
Taiwan has implied China was to blame for the failed deal, while China has blamed Taiwan for trying to circumvent Fosun.
BioNTech said in February it planned to provide the vaccine to Taiwan, but has not provided further details and declined to comment on the progress of talks in a statement to Reuters this week.
China claims Taiwan as its own territory, and has repeatedly sparred with the island over the coronavirus pandemic. Taiwan has accused China of spreading fake news, which Beijing denies.
Taiwan has received only around 700,000 vaccine doses to date, all from AstraZeneca (NASDAQ:AZN) Plc, and those are rapidly running out as it steps up vaccinations during a spike in domestic infections.
Taiwan has millions more doses on order, including from Moderna (NASDAQ:MRNA) Inc, but like many other parts of the world has faced delivery delays due to global shortages.
NEW YORK (Reuters) - Wells Fargo (NYSE:WFC) & Co told staff on Monday it will reimburse employees and their dependents for travel and lodging costs associated with traveling...
(Reuters) - Airlines canceled over 700 flights in the United States on Monday, as adverse weather and a shortage of staff hurt their ability to keep up with a surge in summer...
By Lisa Pauline Mattackal and Medha Singh (Reuters) - Bitcoin miners have been forced to tap into their cryptocurrency stashes as a plunge in prices, rising energy costs and...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.